Clinical Trial: An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title:

Brief Summary: This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.

Detailed Summary:
Sponsor: Allergan

Current Primary Outcome: Percentage of Subjects Satisfied With Latisse® [ Time Frame: Day 1 ]

Overall subject satisfaction with Latisse® was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.


Original Primary Outcome: Percentage of Subjects Satisfied With Latisse® [ Time Frame: Day 1 ]

Current Secondary Outcome:

  • Number of Applications of Latisse® Per Week [ Time Frame: Day 1 ]
    Number of applications of Latisse® per week as reported by the subjects.
  • Percentage of Subjects Satisfied Wtih Their Eyelashes [ Time Frame: Day 1 ]
    Overall subject satisfaction with their eyelashes was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.


Original Secondary Outcome:

  • Number of Applications of Latisse® Per Week [ Time Frame: Day 1 ]
  • Percentage of Subjects Satisfied Wtih Their Eyelashes [ Time Frame: Day 1 ]


Information By: Allergan

Dates:
Date Received: June 18, 2012
Date Started: November 2010
Date Completion:
Last Updated: August 16, 2012
Last Verified: August 2012